Liothyronine sodium
- Product NDC
- 71335-1943
- 11-digit product format
- 713351943
- Labeler code
- 71335
- Product ID
- 71335-1943_ea5f289f-acad-4c98-8e81-82f2d3ed5855
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Liothyronine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA214803
- Marketing category
- ANDA
- Marketing start
- 2021-02-01
- Substance
- LIOTHYRONINE SODIUM
- Active strength
- 25 ug/1
- Pharmacologic classes
- Triiodothyronine [CS], l-Triiodothyronine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Liothyronine sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LIOTHYRONINE SODIUM | 25 ug/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GCA9VV7D2N |
| Rxcui | 903697 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1943-1 | 71335194301 | 30 TABLET in 1 BOTTLE (71335-1943-1) | 30 tablet | 2021-11-10 | 0000-00-00 | No | No | Current |
| 71335-1943-2 | 71335194302 | 28 TABLET in 1 BOTTLE (71335-1943-2) | 28 tablet | 2024-09-06 | 0000-00-00 | No | No | Current |
| 71335-1943-3 | 71335194303 | 60 TABLET in 1 BOTTLE (71335-1943-3) | 60 tablet | 2021-11-10 | 0000-00-00 | No | No | Current |
| 71335-1943-4 | 71335194304 | 100 TABLET in 1 BOTTLE (71335-1943-4) | 100 tablet | 2024-09-06 | 0000-00-00 | No | No | Current |
| 71335-1943-5 | 71335194305 | 90 TABLET in 1 BOTTLE (71335-1943-5) | 90 tablet | 2024-09-06 | 0000-00-00 | No | No | Current |